undefined undefined
NaN.000
NaN.00%
Oppenheimer analyst Francois Brisebois maintained a Buy rating on Aquestive The...
05-14 19:55
Aquestive Therapeutics shares are trading lower after the company reported wors...
05-08 20:49
Cash and cash equivalents were $95.2 million as of March 31, 2024. Extended cash runway into 2026 with completion of $77.5 million underwritten public offering with high quality
05-08 06:02
Aquestive Therapeutics (NASDAQ:AQST) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.07) by 142.86 percent. This is a 254.55 percent decrease over earnings of $0.11 per
05-08 05:48
The latest update is out from Aquestive Therapeutics (AQST). The Company has re...
05-08 04:33
Unity Software(U.US) reported fourth-quarter financial results after the market...
04-30 18:30
Analyst Ram Selvaraju of H.C. Wainwright reiterated a Buy rating on Aquestive T...
04-30 18:18
Shares of Aquestive Therapeutics (NASDAQ:AQST) were down 12% in early afternoon trading Monday after the company said it had received FDA approval for pediatric use of its drug Libervant and that it e...
04-30 01:56
Gainers: Deciphera Pharmaceuticals (DCPH) +72%. Koninklijke Philips N.V. ADR (PHG) +35%. ImmunityBio (IBRX) +38%. Soleno Therapeutics (SLNO) +31%. ZyVersa Therapeutics (ZVSA) +23%. Losers: Clever Leav...
04-29 22:02
The U.S. Food and Drug Administration (FDA) has approved Libervant, a diazepam formulation developed as an oral rescue therapy by Aquestive Therapeutics (NASDAQ:AQST) for the treatment of seizures. Ac...
04-27 20:09